DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix

Young Kwang Chae, Megan Othus, Sandip P Patel, Floortje J Backes, David M O’Malley, Mihaela Cristea, Aung Naing, Katherine Kurnit, Ramez N Eskander, Scott T Goodrich, William R Robinson, Jennifer Scalici, John Chan, Hussein Ali-Ahmad, John Hays, Colleen McCormick, Edward J Kim, Thanasak Sueblinvong, Amina Ahmed, Jean Siedel, Jessica Thomes Pepin, Justin Neal Bottsford-Miller, Seth Olusegun Fagbemi, Anthony John Jaslowski, Hye Sung Kim, Liam Il-Young Chung, Carolyn Moloney-Lineen, Christine M McLeod, Helen X Chen, Elad Sharon, Howard Streicher, Christopher W Ryan, Charles D Blanke, Razelle Kurzrock

Open source

DOI: 10.1136/jitc-2025-012805
Published: 2026-02
Container: Journal for ImmunoTherapy of Cancer
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2025-012805,
  title = {DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix},
  author = {Young Kwang Chae and Megan Othus and Sandip P Patel and Floortje J Backes and David M O’Malley and Mihaela Cristea and Aung Naing and Katherine Kurnit and Ramez N Eskander and Scott T Goodrich and William R Robinson and Jennifer Scalici and John Chan and Hussein Ali-Ahmad and John Hays and Colleen McCormick and Edward J Kim and Thanasak Sueblinvong and Amina Ahmed and Jean Siedel and Jessica Thomes Pepin and Justin Neal Bottsford-Miller and Seth Olusegun Fagbemi and Anthony John Jaslowski and Hye Sung Kim and Liam Il-Young Chung and Carolyn Moloney-Lineen and Christine M McLeod and Helen X Chen and Elad Sharon and Howard Streicher and Christopher W Ryan and Charles D Blanke and Razelle Kurzrock},
  year = {2026},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2025-012805},
  url = {https://doi.org/10.1136/jitc-2025-012805}
}

RIS

TY  - JOUR
TI  - DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix
AU  - Young Kwang Chae
AU  - Megan Othus
AU  - Sandip P Patel
AU  - Floortje J Backes
AU  - David M O’Malley
AU  - Mihaela Cristea
AU  - Aung Naing
AU  - Katherine Kurnit
AU  - Ramez N Eskander
AU  - Scott T Goodrich
AU  - William R Robinson
AU  - Jennifer Scalici
AU  - John Chan
AU  - Hussein Ali-Ahmad
AU  - John Hays
AU  - Colleen McCormick
AU  - Edward J Kim
AU  - Thanasak Sueblinvong
AU  - Amina Ahmed
AU  - Jean Siedel
AU  - Jessica Thomes Pepin
AU  - Justin Neal Bottsford-Miller
AU  - Seth Olusegun Fagbemi
AU  - Anthony John Jaslowski
AU  - Hye Sung Kim
AU  - Liam Il-Young Chung
AU  - Carolyn Moloney-Lineen
AU  - Christine M McLeod
AU  - Helen X Chen
AU  - Elad Sharon
AU  - Howard Streicher
AU  - Christopher W Ryan
AU  - Charles D Blanke
AU  - Razelle Kurzrock
PY  - 2026
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2025-012805
UR  - https://doi.org/10.1136/jitc-2025-012805
ER  -

APA

Chae, Y. K., Othus, M., Patel, S. P., Backes, F. J., O’Malley, D. M., Cristea, M., Naing, A., Kurnit, K., Eskander, R. N., Goodrich, S. T., Robinson, W. R., Scalici, J., Chan, J., Ali-Ahmad, H., Hays, J., McCormick, C., Kim, E. J., Sueblinvong, T., Ahmed, A., Siedel, J., Pepin, J. T., Bottsford-Miller, J. N., Fagbemi, S. O., Jaslowski, A. J., Kim, H. S., Chung, L. I., Moloney-Lineen, C., McLeod, C. M., Chen, H. X., Sharon, E., Streicher, H., Ryan, C. W., Blanke, C. D., & Kurzrock, R. (2026). DART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-012805

Source records

crossref · retrieved 2026-09-25T07:44:00.636Z